Stay updated with breaking news from Pediatric Classic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CAHmelia-203 Study of Tildacerfont in Adult Classic Congenital Adrenal Hyperplasia with Severe Hyperandrogenemia Did Not Meet Primary Efficacy Endpoint Positive Data from CAHptain-205 Study of...
Enrollment Completed in CAHptain-205 Study in Pediatric Classic Congenital Adrenal Hyperplasia (CAH)Target Enrollment Completed in CAHmelia-203 Study in Adult Classic CAHCAHmelia-204 Study in Adult Classic CAH on Track to Complete Enrollment in Early Q1 2024SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Spruce Biosci...
CAHmelia Program in Adult Classic Congenital Adrenal Hyperplasia Achieves 50% Enrollment in CAHmelia-204 and Approaches 75% Enrollment in CAHmelia-203 Enrollment in P.O.W.E.R. Study for Polycystic... | May 15, 2023